3.0.0 1378 2019-11-15T21:33:20Z 2019-11-15T21:33:20Z House H HR 2005-03-17 109 hsju00 Judiciary Committee House Standing hsju08 Crime and Federal Government Surveillance Subcommittee Referred to 2005-04-04T21:31:18Z Referred to 2005-03-17T15:04:25Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-03-22T22:07:19Z Referred to 2005-03-17T15:04:20Z 2005-04-04 hsju08 Crime and Federal Government Surveillance Subcommittee 1 House committee actions Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Committee 2005-03-22 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-03-17 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2005-03-17 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2005-03-17 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-03-17 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-03-17 Introduced in House IntroReferral 1000 9 Library of Congress E000172 Rep. Emerson, Jo Ann [R-MO-8] JO EMERSON R MO ANN 8 N B000420 Rep. Berry, Marion [D-AR-1] MARION BERRY D AR 1 2005-03-17 True S000465 Rep. Skelton, Ike [D-MO-4] IKE SKELTON D MO 4 2005-05-03 False H000948 Rep. Hulshof, Kenny C. [R-MO-9] KENNY HULSHOF R MO C. 9 2005-05-09 False B001254 Rep. Boren, Dan [D-OK-2] Dan Boren D OK 2 2005-05-12 False W000119 Rep. Wamp, Zach [R-TN-3] ZACH WAMP R TN 3 2005-06-23 False Crime and Law Enforcement Chemicals Commerce Drug abuse Drug industry Drug law enforcement Drug traffic Drugs Health Methamphetamine Retail trade Crime and Law Enforcement 00 2005-03-17 Introduced in House 2005-12-15T20:09:12Z Ephedrine Alkaloids Regulation Act of 2005 - Requires ephedrine alkaloids (including ephedrine and pseudoephedrine) and phenylpropanolamine to be listed in schedule V of the Controlled Substances Act (CSA) (drugs or other substances that have a low potential for abuse and that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence). Excepts pseudoephedrine and phenylpropanolamine when contained in a drug that is in liquid or gel form marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act (FDCA), which shall be considered a listed chemical. Makes such requirement and exception subject to the Attorney General's authority to designate substances as controlled or listed chemicals.

Amends CSA to revise the definition of "regulated transaction" to: (1) provide that the threshold for any distributor sale of products containing pseudoephedrine products in liquid or gel form, or containing phenylpropanolamine products, shall be nine grams of pseudoephedrine or phenylpropanolamine; and (2) specify as a "chemical mixture" a transaction in which is excluded from such definition a mixture that may be marketed or distributed lawfully in the United States under FDCA.

]]> Ephedrine Alkaloids Regulation Act of 2005 Short Titles as Introduced Ephedrine Alkaloids Regulation Act of 2005 Display Title Ephedrine Alkaloids Regulation Act of 2005 Official Title as Introduced To amend the Controlled Substances Act with respect to the regulation of ephedrine alkaloids, including ephedrine and pseudoephedrine, and for other purposes. Introduced in House 2005-03-17T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr1378ih/xml/BILLS-109hr1378ih.xml 2005-04-04 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.